Drug Profile
TTP 355
Alternative Names: TTP355Latest Information Update: 19 May 2020
Price :
$50
*
At a glance
- Originator TransTech Pharma
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Glucokinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Type 2 diabetes mellitus